Key Metrics of Agios Pharmaceuticals
Revenue$26.8M▲ 88.4% YoYFY 2023
Operating income−$391M▼ 0.6% YoY
Net profit−$352M▼ 51.7% YoY
Shareholders' equity$811M
Market cap$2.2BAGIO · $37.19
Competitors10identified
About Agios Pharmaceuticals
Sectors
Company details
- Website
- agios.com
- Founded
- 2013
- Listed
- Nasdaq: AGIO (since 2013)
Operational Areas of Agios Pharmaceuticals
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameAgios Pharmaceuticals Inc.
TickerAGIO
ExchangeNasdaq
CountryUnited States
SEC CIK0001439222
Listed since2013
IndustryBiotechnology: Pharmaceutical Preparations
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Websitehttp://www.agios.com
US market & SEC filings
AGIO · Nasdaq · SEC CIK 0001439222
Last price · 25 Oct 2026
$37.19
+0.03%
Market cap$2.2B
P/E—On FY 2023 diluted EPS
Volume931,127
SectorHealth CareBiotechnology: Pharmaceutical Preparations
Country · IPOUnited StatesListed 2013
AGIO share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeCambridge
GSTIN—
Email—
Websitehttp://www.agios.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Agios Pharmaceuticals
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
pharmaceutical industry
Filings
No filings on record yet.